ROCK2 increases drug resistance in acute myeloid leukemia via metabolic reprogramming and MAPK/PI3K/AKT signaling
Muxia Yan, Xin Luo, Hong Han, Jiachun Qiu, Qian Ye, Li Zhang, Yiqian Wang
Topics & Concepts
Protein kinase BROCK2Myeloid leukemiaCancer researchPI3K/AKT/mTOR pathwayKinaseBiologyUbiquitin ligaseSignal transductionCell biologyRho-associated protein kinaseBiochemistryUbiquitinGeneCancer, Hypoxia, and MetabolismProtein Degradation and InhibitorsAcute Myeloid Leukemia Research